Cat. #151084
Anti-HPV16L1 [CamVir 1]
Cat. #: 151084
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: Human papilloma virus type 16, major capsid protein L1 (HPV16 L1)
Class: Monoclonal
Application: ELISA ; IHC ; IP ; WB
Reactivity: Human papilloma virus
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Lawrence Banks
Institute: University of Cambridge
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-HPV16L1 [CamVir 1]
- Cancer: Gynaecologic cancer
- Cancers detailed: Cervical
- Research fields: Cancer;Microbiology
- Clone: CamVir 1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 56 kDa
- Strain: Balb/c
- Reactivity: Human papilloma virus
- Host: Mouse
- Application: ELISA ; IHC ; IP ; WB
- Description: The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases, and HPV-1, which is associated with benign cutaneous warts. HPV late protein L1 is the major capsid protein.
- Immunogen: A b galactosidase-L1 fusion protein purified by PAGE.
- Isotype: IgG2a
- Myeloma used: NS0
Target Details
- Target: Human papilloma virus type 16, major capsid protein L1 (HPV16 L1)
- Molecular weight: 56 kDa
- Target background: The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases, and HPV-1, which is associated with benign cutaneous warts. HPV late protein L1 is the major capsid protein.
Applications
- Application: ELISA ; IHC ; IP ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: '-15° C to -25° C
- Shipping conditions: Shipping at 4° C
Related Tools
- Related tools: Anti-HPV16E6 & HPV18E6, Recombinant [C1P5]
References
- Day et al. 2012. Clin Vaccine Immunol. 19(7):1075-82. PMID: 22593236.
- A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.
- Steele et al. 2005. Br J Cancer. 93(2):248-59. PMID: 15986031.
- T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.
- Zhang et al. 1998. Virology. 243(2):423-31. PMID: 9568041.
- Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.
- McLean et al. 1990. J Clin Pathol. 43(6):488-92. PMID: 2166093.
- Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.
